Seaweed is a promising source of anti-obesity agents, including polysaccharides, proteins, polyphenols, carotenoids, and n-3 long-chain polyunsaturated fatty acids. The anti-obesity effects of such compounds may be due to several mechanisms, including inhibition of lipid absorption and metabolism, effect on satiety, and inhibition of adipocyte differentiation. The aim of this study was to assess the evidence from human randomized controlled trials for the effects of seaweed on body-weight status as well as lipid and nonlipid parameters in adults with overweight and obesity. Four databases—Medline, Scopus, Web of Science, and Cochrane Library—were searched from December 2022 to June 2023 using the following key words: Seaweed OR fucoxanthin OR alginates OR fucoidans OR phlorotannin’s OR macroalgae OR marine algae AND obesity OR overweight OR BMI OR body mass index. Eleven interventional studies (10 parallel and 1 crossover) were extracted. Meta-analysis showed a significant effect, favoring the intervention group for BMI (body mass index) (standardized mean difference [SMD]: -0.40; 95% CI: -0.65 to -0.16 kg/m2; P = 0.0013) and percentage of fat mass (SMD: -1.48; 95% CI: -2.66% to -0.30%, P = 0.0138). The results were seen when refined or extracted brown seaweed (BMI) or only refined brown seaweed (% fat mass) were administered to participants for at least 8 weeks. Moreover, a significant overall effect of seaweed supplementation on total cholesterol (SMD: -7.72; 95% CI: -12.49 to -2.95 mg/dL; P = 0.0015) and low-density-lipoprotein cholesterol (SMD: -7.33; 95% CI: -11.64 to -3.02 mg/dL; P < 0.001) was noted. Any significant effects of seaweed on glucose metabolism were not shown. Edible seaweed supplementation shows potential for managing obesity and disorders of the blood lipid profile when administered to participants for at least 8 weeks. PROSPERO registration no. CRD42022378484 (www.crd.york.ac.uk/PROSPERO).
1 November 1994 in Clinical and Experimental Pharmacology and Physiology
Diet-derived nitrite can benefit cardiovascular function. However, the effects of nitrite supplementation on idiopathic intracerebral hemorrhage (spontaneous ICH) are unclear. This study, therefore, investigated the impacts of chronic nitrite supplementation on the survival rate and risk for spontaneous ICH in stroke-prone spontaneously hypertensive/Izumo strain (SHRSP/Izm) rats fed with a high-salt diet. Experimental study I-six-week-old male rats were categorized into two groups: (1) SHRSP+salt, in which rats were administered saline drinking water, and (2) SHRSP+salt+ nitrite, in which rats were administered nitrite-added saline drinking water for 14 weeks each. The survival curves during this period did not vary significantly between the groups. However, nitrite administration markedly reduced the incidence of ICH and the extent of cerebral hemorrhage. Experimental study II-the impacts of nitrite supplementation on blood pressure in salt-loaded 8-week-old male SHRSP/Izm rats were evaluated for >4 weeks. During the first week, systolic blood pressure was remarkably lower in the nitrite group than in the control (without nitrite feeding). Similarly, at week 4, cardiac mass and brain mass were significantly lower. In conclusion, nitrite treatment reduced the extent of cerebral hemorrhage caused by hypertension and administration of a high-salt diet.